tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

OCS Stock Latest News

Oculis price target raised to $32 from $29 at H.C. Wainwright
The FlyOculis price target raised to $32 from $29 at H.C. Wainwright
2d ago
OCS
Oculis Holding’s Promising Future: Advancements in Neuroprotection, Dry Eye Treatment, and Diabetic Macular Edema
PremiumRatings
Oculis Holding’s Promising Future: Advancements in Neuroprotection, Dry Eye Treatment, and Diabetic Macular Edema
2d ago
OCS
Oculis Holding AG Unveils Key Clinical Updates and Future Outlook at R&D Day
PremiumCompany Announcements
Oculis Holding AG Unveils Key Clinical Updates and Future Outlook at R&D Day
3d ago
6K
OCS
Oculis Holding’s Promising Pipeline and Strategic FDA Alignments Support Buy Rating
PremiumRatings
Oculis Holding’s Promising Pipeline and Strategic FDA Alignments Support Buy Rating
1M ago
OCS
Oculis price target raised to $41 from $37 at Baird
PremiumThe Fly
Oculis price target raised to $41 from $37 at Baird
1M ago
OCS
Oculis price target raised to $32 from $31 at BofA
PremiumThe FlyOculis price target raised to $32 from $31 at BofA
1M ago
OCS
Oculis price target lowered to $29 from $30 at H.C. Wainwright
Premium
The Fly
Oculis price target lowered to $29 from $30 at H.C. Wainwright
1M ago
OCS
Oculis Holding AG Faces Heightened Cybersecurity Risks Amid Geopolitical Tensions
Premium
Company Announcements
Oculis Holding AG Faces Heightened Cybersecurity Risks Amid Geopolitical Tensions
1M ago
OCS
Oculis Holding AG Reports 2024 Financial Results
PremiumCompany Announcements
Oculis Holding AG Reports 2024 Financial Results
1M ago
OCS
Oculis Holding’s Promising Ophthalmology Portfolio and Financial Stability Lead to Buy Rating
PremiumRatings
Oculis Holding’s Promising Ophthalmology Portfolio and Financial Stability Lead to Buy Rating
1M ago
OCS
Oculis Holding AG Reports 2024 Financial Results and Clinical Progress
PremiumCompany Announcements
Oculis Holding AG Reports 2024 Financial Results and Clinical Progress
1M ago
6K
OCS
Oculis 5M share Secondary priced at $20,00
PremiumThe Fly
Oculis 5M share Secondary priced at $20,00
2M ago
OCS
Oculis Holding AG Prices $100 Million Oversubscribed Share Offering
PremiumCompany AnnouncementsOculis Holding AG Prices $100 Million Oversubscribed Share Offering
2M ago
6K
OCS
Oculis price target raised to $31 from $23 at BofA
Premium
The Fly
Oculis price target raised to $31 from $23 at BofA
3M ago
OCS
Oculis Holding’s OCS-05 Shows Promising Results in Phase 2 Trial for Acute Optic Neuritis
Premium
Company Announcements
Oculis Holding’s OCS-05 Shows Promising Results in Phase 2 Trial for Acute Optic Neuritis
3M ago
6K
OCS
Oculis Holding (OCS): A Biopharma Opportunity for Adventurous Investors
PremiumMarket News
Oculis Holding (OCS): A Biopharma Opportunity for Adventurous Investors
4M ago
OCS
Oculis Holding AG Reports Q3 2024 Financial Progress
PremiumCompany Announcements
Oculis Holding AG Reports Q3 2024 Financial Progress
5M ago
OCS
Oculis Holding’s Financial Struggles Amid Asset Growth
PremiumCompany Announcements
Oculis Holding’s Financial Struggles Amid Asset Growth
5M ago
6K
OCS
Oculis Holding Ag (OCS) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Oculis Holding Ag (OCS) Q3 Earnings Cheat Sheet
5M ago
OCS
Oculis accelerates patient enrollment for both Phase 3 DIAMOND trials
PremiumThe FlyOculis accelerates patient enrollment for both Phase 3 DIAMOND trials
6M ago
OCS
Oculis files to sell 361,011 ordinary shares for holders
Premium
The Fly
Oculis files to sell 361,011 ordinary shares for holders
8M ago
OCS
Oculis Holding Shows Strong Asset and Equity Growth
Premium
Company Announcements
Oculis Holding Shows Strong Asset and Equity Growth
8M ago
6K
OCS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >